Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy

Show full item record



Permalink

http://hdl.handle.net/10138/339484

Citation

Gao , Y , Tong , H , Li , J , Li , J , Huang , D , Shi , J & Xia , B 2021 , ' Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy ' , Frontiers in Bioengineering and Biotechnology , vol. 9 , 720508 . https://doi.org/10.3389/fbioe.2021.720508

Title: Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy
Author: Gao, Yan; Tong, Haibei; Li, Jialiang; Li, Jiachen; Huang, Di; Shi, Jisen; Xia, Bing
Contributor organization: Divisions of Faculty of Pharmacy
Date: 2021-08-19
Language: eng
Number of pages: 18
Belongs to series: Frontiers in Bioengineering and Biotechnology
ISSN: 2296-4185
DOI: https://doi.org/10.3389/fbioe.2021.720508
URI: http://hdl.handle.net/10138/339484
Abstract: Nanomedicines have been designed and developed to deliver anticancer drugs or exert anticancer therapy more selectively to tumor sites. Recent investigations have gone beyond delivering drugs to tumor tissues or cells, but to intracellular compartments for amplifying therapy efficacy. Mitochondria are attractive targets for cancer treatment due to their important functions for cells and close relationships to tumor occurrence and metastasis. Accordingly, multifunctional nanoplatforms have been constructed for cancer therapy with the modification of a variety of mitochondriotropic ligands, to trigger the mitochondria-mediated apoptosis of tumor cells. On this basis, various cancer therapeutic modalities based on mitochondria-targeted nanomedicines are developed by strategies of damaging mitochondria DNA (mtDNA), increasing reactive oxygen species (ROS), disturbing respiratory chain and redox balance. Herein, in this review, we highlight mitochondria-targeted cancer therapies enabled by nanoplatforms including chemotherapy, photothermal therapy (PTT), photodynamic therapy (PDT), chemodynamic therapy (CDT), sonodynamic therapy (SDT), radiodynamic therapy (RDT) and combined immunotherapy, and discussed the ongoing challenges.
Subject: mitochondria targeting
nanomedicine
enhanced efficacy
photothermal therapy (PTT)
chemoteraphy
immunotherapy
DRUG-DELIVERY
PHOTODYNAMIC THERAPY
LOW TOXICITY
IN-VITRO
NANOPARTICLES
TUMOR
CELLS
NANOCOMPOSITES
HYPERTHERMIA
DOXORUBICIN
11832 Microbiology and virology
3122 Cancers
317 Pharmacy
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
fbioe_09_720508.pdf 3.240Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record